Jafral will be supporting Phage Therapy 2024 Conference

It is a great pleasure to announce that JAFRAL is supporting the 7th World Conference Targeting Phage Therapy, to be held on June 20-21 in Malta.


JAFRAL is world leading Contract Development and Manufacturing Organization (CDMO) for Bacteriophages! JAFRAL offers development and manufacturing services for phage-based product to be used in different fields: Human therapeutics, Veterinary, Food industry, Agriculture, Cosmetics, etc.

JAFRAL, with its capacity of producing up to 200L batches, has long track record of producing GMP products, which also includes production of Clinical Trial Material for 12 Clinical trials, performed in US, EU and Australia. JAFRAL offers liquid formulations, spray drying and lyophilization.

Communication at Phage Therapy 2024

JAFRAL’s CEO, Dr. Frenk Smrekar, will give a short oral presentation on the “Production of Phage Products for Various Applications”.

In his talk, he will highlight the following:

  • High quality phage products
  • GMP/non-GMP production
  • Spray-drying / Lyophilization
  • Analytical testing
  • Clinical trial material
  • Production of compassionate use material

Join Dr. Smrekar on June 20-21 at Corinthia Palace Malta to know more about JAFRAL’s services and production process.

Company website: https://jafral.com/

Targeting Phage Therapy 2024
7th World Conference
June 20-21, 2024 – Corinthia Palace, Malta